Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00242437 · ClinicalTrials.gov registry record · Phase 4
Hemostatic Matrix in Endoscopic Sinus Surgery
A Phase 4 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00242437 is a Phase 4 study that has completed, run by Ethicon. The registered enrollment target is 30 participants.
The verdict
NCT00242437, a Phase 4 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Evaluating clinical performance of Hemostatic Matrix with bovine thrombin in achieving hemostasis in patients undergoing endoscopic sinus surgery.
Interventions
- DEVICE Hemostatic matrix
- DEVICE bovine thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00242437
The ClinicalTrials.gov registry entry for NCT00242437 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hemostatic matrix is the first listed.
NCT00242437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00242437 about?
NCT00242437 is a clinical study titled "Hemostatic Matrix in Endoscopic Sinus Surgery". Evaluating clinical performance of Hemostatic Matrix with bovine thrombin in achieving hemostasis in patients undergoing endoscopic sinus surgery.
What is the current status of trial NCT00242437?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00242437?
The interventions under investigation include: Hemostatic matrix (DEVICE), bovine thrombin (DEVICE).
Who is sponsoring clinical trial NCT00242437?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.